The introduction of Retatrutide ZPHC, at a concentration of 120mg, is sparking considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 receptor medication appears to provide impressive improvements in weight loss compared to existing therapies. Early patient studies have shown marked decreases in body fat percenta